Literature DB >> 6783355

Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.

J L Preud'Homme, L Morel-Maroger, J C Brouet, E Mihaesco, J P Mery, M Seligmann.   

Abstract

In a patient treated for IgA kappa myeloma, bone marrow relapse and a sharp drop in the serum IgA level paralleled tissue deposition of non-amyloid material reactive with anti-kappa anti-alpha sera in immunofluorescence studies of kidney and liver biopsies. Clinical manifestations were progressive renal failure with nephrotic syndrome, with both tubular and glomerular lesions (including nodular glomerulosclerosis), hepatomegaly, cardiac and neurological symptoms. Biosynthesis experiments showed the production of alpha chains diminished in length by about one domain which were rapidly degraded predominantly after secretion and of two species of light chains; normal-sized light chains which assembled with alpha chains and abnormally short ones which were secreted as free light chains. The apparent molecular weight of the light chains was larger in secretions than in cytoplasmic extracts, suggesting their glycosylation. These results suggest a causal relationship between tissue deposition and production of abnormal immunoglobulins by a variant clone, the emergence of which was possibly induced by Melphalan therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6783355      PMCID: PMC1537144     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Variants of mouse myeloma cells that produce short immunoglobulin heavy chains.

Authors:  B K Birshtein; J L Preud'homme; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

2.  Mutagenesis of mouse myeloma cells with 'Melphalan'.

Authors:  J L Prend'homme; J Buxbaum; M D Scharff
Journal:  Nature       Date:  1973-10-12       Impact factor: 49.962

Review 3.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

4.  Mesangial thickening and nodular glomerular sclerosis in diabetes mellitus and other diseases.

Authors:  S Olsen
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1972

5.  The primary structure of a monoclonal human lambda-type immunoglobulin L-chain of subgroup II (Bence-Jones protein NEI).

Authors:  F A Garver; N Hilschmann
Journal:  Eur J Biochem       Date:  1972-03-15

6.  Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins.

Authors:  H L Spiegelberg; C A Abel; B G Fishkin; H M Grey
Journal:  Biochemistry       Date:  1970-10-13       Impact factor: 3.162

Review 7.  Manifestations of systemic light chain deposition.

Authors:  R E Randall; W C Williamson; F Mullinax; M Y Tung; W J Still
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

8.  Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia.

Authors:  J L Preud'homme; M Seligmann
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Pathology of the kidney in Waldenström's macroglobulinemia. Study of sixteen cases.

Authors:  L Morel-Maroger; A Basch; F Danon; P Verroust; G Richet
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

10.  Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains.

Authors:  H C Sox; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

View more
  13 in total

1.  Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient.

Authors:  M P Grassi; F Clerici; C Perin; M Borella; A Gendarini; A Quattrini; R Nemni; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

Authors:  A A Khamlichi; P Aucouturier; C Silvain; M Bauwens; G Touchard; J L Preud'homme; F Nau; M Cogné
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

3.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Portal hypertension related to light chain deposition disease of liver: an enlightening experience.

Authors:  Arunansu Talukdar; Kabita Mukherjee; Dibbendhu Khanra; Manjari Saha
Journal:  BMJ Case Rep       Date:  2013-05-29

5.  Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.

Authors:  A Rocca; A A Khamlichi; P Aucouturier; L H Noël; L Denoroy; J L Preud'homme; M Cogné
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 6.  Renal lesions in dysproteinemias.

Authors:  P Verroust; L Morel-Maroger; J L Preud'Homme
Journal:  Springer Semin Immunopathol       Date:  1982

7.  Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.

Authors:  Spyros Michopoulos; Kalliopi Petraki; Constantina Petraki; Meletios-Athanasios Dimopoulos
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

8.  Primary cardiovascular amyloidosis with benign monoclonal gammopathy.

Authors:  L Pajor; G Kelényi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

10.  Immunoglobulin synthesis in primary and myeloma amyloidosis.

Authors:  J L Preud'homme; D Ganeval; J P Grünfeld; L Striker; J C Brouet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.